KIKK Capital

KIKK Capital is a venture capital firm based in Roosendaal, Netherlands, founded in 2016. The firm focuses on investing in young companies that have recently developed and launched innovative products, processes, or services. KIKK Capital not only provides financial support but also contributes valuable expertise, skills, and network connections to help these start-ups succeed. The firm primarily targets investments in Netherlands-based start-ups, fostering growth and development within the local entrepreneurial ecosystem.

Bas Van Berkum

Investment Manager

Fatih Kaya

Finance and Investment Professional and Investment Manager

Johan Sebregts

Founder and Managing Partner

Jan Theunissen

Senior Investment Manager

5 past transactions

Chromodynamics

Seed Round in 2024
Chromodynamics is a deep tech company creating a range of multispectral cameras that can take photos of the composition of materials in real time.

Secret View

Series A in 2022
Secret View is a community platform focused on enhancing customer experience through feedback and insights. It enables users to publish their assignments and facilitates a process of becoming proficient feedback providers by offering e-learning, personal support, and quality checks. Additionally, Secret View operates as a market research agency, providing organizations with affordable solutions to continuously learn from real customer experiences. By utilizing mystery shopping research, the company assists retail and hospitality chains in measuring and optimizing their customer service, thereby enhancing overall business performance.

River BioMedics

Seed Round in 2022
River BioMedics is a biotechnology company focused on developing 3D human heart tissue for pre-clinical drug testing. Recognizing that pharmaceutical companies face significant challenges in drug development, including high costs and a 90% failure rate primarily due to drug-induced cardiac toxicity, River BioMedics aims to address these issues by creating advanced 3D cardiac models. These models closely mimic the functioning human heart and are designed to provide clinically relevant insights during drug discovery and toxicity screening. By utilizing a multidisciplinary approach based on human stem cells, the company offers innovative tools for healthcare professionals to validate drug targets and enhance the understanding of how various compounds affect cardiac function.

Pepscope

Venture Round in 2020
Pepscope BV is a biotechnology company based in Nijmegen, the Netherlands, specializing in the development of innovative protein kinase activity profiling technologies. Founded in 2012, the company focuses on creating solutions that enhance the discovery and development of novel kinase inhibitors and other therapeutic compounds. Pepscope offers its flagship product, QuantaKinome, to the pharmaceutical industry and academic researchers, facilitating the identification of new applications for existing compounds and aiding in the selection of optimal therapies tailored to individual patients. In addition to kinase profiling assays, Pepscope provides advanced proteomics services, utilizing microarray and mass spectrometry techniques to deliver reproducible results and robust conclusions for research and diagnostics.

Toxys

Venture Round in 2020
Toxys is a Dutch biotechnology company specializing in in vitro toxicity screening solutions that help identify hazardous and potential carcinogenic properties of novel compounds. By offering advanced technology that assesses genotoxicity and developmental toxicity, Toxys enables its customers to make informed decisions during the early phases of product and drug development. The company's innovative approach contributes to the creation of safer medicines and products while also aiming to reduce the reliance on animal testing in research and development processes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.